Patients Interested in Learning About Preeclampsia Risk
By Lori Solomon HealthDay Reporter
WEDNESDAY, March 27, 2024 -- The majority of childbearing-age people would value predictive testing for preeclampsia and report they would act on this information, according to a study published online March 13 in BMC Pregnancy and Childbirth.
Alison Cowan, M.D., from Mirvie Inc. in San Francisco, and colleagues evaluated baseline sentiments on pregnancy care and medication amenability and how these measures would be impacted by early predictive testing for preeclampsia. The analysis included data from 1,022 digital survey participants.
The researchers found that 75 percent of respondents reported they have a “good understanding” of preeclampsia, but measured knowledge was low, with only 10 percent able to identify five common signs or symptoms of preeclampsia. The majority of participants (91 percent) wanted early pregnancy predictive testing for preeclampsia, with 88 percent saying if they were at high risk they would be more motivated to follow their provider’s medication recommendations and 94 percent saying they would desire home blood pressure monitoring. High rates of motivation to change behavior and adhere to medication were even seen among individuals who are more medication-hesitant if predictive testing showed a high risk for preeclampsia.
"Improved detection of at-risk individuals through objective testing combined with increased adherence to their recommended care plan may be an important step to remedy the growing gap in prevention," the authors write.
The study authors were all employed by Mirvie Inc., the study’s funder.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Echocardiogram Can ID Women With Preeclampsia at Risk for Future HTN
WEDNESDAY, June 26, 2024 -- Echocardiography during pregnancy or early postpartum can assist in identifying women with preeclampsia at greater risk of future hypertension...
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
NT-proBNP, IL-1RL Can Identify High-Risk Congenital Heart Disease in Neonates
MONDAY, June 24, 2024 -- Automated quantitative tests for NT-proBNP and interleukin 1 receptor-like 1 (IL-1 RL1) can identify high-risk congenital heart disease (CHD) in newborns...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.